Biokine Therapeutics Announces Issuance of Chinese Patent covering the composition and use of novel chemokine binding polypeptides

Biokine Therapeutics Announces Issuance of Chinese Patent covering the composition and use of novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation, and cancer (BKT130 project). Read More

BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatmen

BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment The phase 1 trial of BKT-140/BL-8040 is expected to begin in Q3 2014, with results expected in late 2014 or early 2015. BKT-140/BL-8040 is also in Phase 2 for AML, with results expected in early 2015. Read More [...]

Go to Top